Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,549 active trials61 approved drugs295 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,963)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07673861 | Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients(CURTAIN) | recruiting | N/A | 100 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT07591701 | Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital | recruiting | N/A | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 26, 2026 |
| clinicaltrials |
| NCT03326713 | Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project(GRACE) | completed | N/A | 668 | Rutgers, The State University of New JerseyOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06599476 | Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy | active not recruiting | N/A | 150 | Advanced Radiation Centers of New YorkOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07321197 | Radical Nephrectomy With vs Without Template Lymph Node Dissection in High-Risk Renal Cell Carcinoma (T-LND RCC)(RECLND) | recruiting | N/A | 220 | Tianjin Medical University Second HospitalOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT07321210 | Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC)(UTLUND) | recruiting | N/A | 150 | Tianjin Medical University Second HospitalOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06359964 | Infective Complications in TP Biopsy Without Antibiotic Prophylaxis | completed | N/A | 1,753 | Chinese University of Hong KongOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT06874985 | Effectiveness and Impact of the Lived Experience Cancer Awareness Campaign on Screening Participation | completed | N/A | 1,264 | International Agency for Research on CancerOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07387263 | Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing | recruiting | N/A | 180 | Unity Health TorontoOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07529080 | Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial | not yet recruiting | N/A | 142 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT02095249 | Prostate Hypoxia - TIC | active not recruiting | N/A | 39 | University Health Network, TorontoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT03142802 | Low-Dose CT - Stage I Testicular Cancer | active not recruiting | N/A | 251 | University Health Network, TorontoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT03254420 | Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.(RCMIGI) | active not recruiting | N/A | 74 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05368207 | Pembrolizumab in Small Cell Carcinoma of Ovary - Hypercalcemic Type Patient(Pemb-HT) | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05562778 | Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment | recruiting | N/A | 150 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05820087 | The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)(#HOPE4KIDNEY) | active not recruiting | N/A | 67 | HistoSonics, Inc.INDUSTRY | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06243510 | Comparison of Apixaban Versus Enoxaparin(CARE) | completed | N/A | 126 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06430749 | Targeted Microwave Tissue Coagulation for Prostate Cancer(MicroPro2) | active not recruiting | N/A | 65 | Osamu UkimuraOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06770855 | Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC) | not yet recruiting | N/A | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07436078 | Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors | recruiting | N/A | 85 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07463833 | Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology | recruiting | N/A | 207 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07663006 | Breast and Cervical Cancer Stigma in Rwanda | not yet recruiting | N/A | 1,116 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT00913939 | High-Dose-Rate Brachytherapy | recruiting | N/A | 500 | University Health Network, TorontoOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT01802242 | Tumor TARGET Prostate Cancer | completed | N/A | 85 | University Health Network, TorontoOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT02918253 | HDR Focal: Feasibility Study | active not recruiting | N/A | 60 | University Health Network, TorontoOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04556916 | Early Detection of Prostate Cancer(PROLIPSY) | recruiting | N/A | 320 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04581109 | Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP)(EPIDROP) | terminated | N/A | 100 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT04770090 | Research of Circulating Tumor Cells Released During Cervical Cancer Surgery(CTC-COL) | active not recruiting | N/A | 200 | University Hospital, MontpellierOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT06213571 | Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas | completed | N/A | 80 | Mayo ClinicOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT06936878 | BOLSTER: Learning New Skills to Thrive(BOLSTER) | recruiting | N/A | 600 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07217353 | The Use of a Novel Vaginal Speculum for Endometrial Biopsies | enrolling by invitation | N/A | 100 | Rocky Vista University, LLCOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07656337 | Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness(IAPSMA) | not yet recruiting | N/A | 10 | Lithuanian University of Health SciencesOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT00969111 | Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy | recruiting | N/A | 70 | Proton Collaborative GroupNETWORK | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05721326 | Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition | completed | N/A | 1,283 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT06543537 | Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer | recruiting | N/A | 112 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07282158 | Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians | recruiting | N/A | 25 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07313839 | Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)(BI-SURE) | recruiting | N/A | 310 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07339384 | Signatera Assessment in Early-Stage Endometrial Cancer(SIGNAL-EMC 101) | not yet recruiting | N/A | 1,010 | Natera, Inc.INDUSTRY | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05471414 | Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer(WFPBD) | active not recruiting | N/A | 76 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07038733 | Investigation of Lymph Node Biology in Kidney Cancer(LN-RCC) | recruiting | N/A | 33 | Yale UniversityOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07625943 | HYPOfractionated RadioTherapy in Cervical Cancer(HYPORT-CC) | recruiting | N/A | 396 | All India Institute of Medical SciencesOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07651124 | To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian Cancer | recruiting | N/A | 6 | Yong Wha MoonOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT04452526 | I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination(IVaccinate) | active not recruiting | N/A | 372 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT05683691 | Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer(VAPOR 2) | active not recruiting | N/A | 400 | Francis Medical Inc.INDUSTRY | 1 | Jun 15, 2026 | clinicaltrials |
| NCT06967961 | Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers(DP-PAN-CANCER) | recruiting | N/A | 450 | Institut Claudius RegaudOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07635108 | MR-guided Single-fraction SBRT for Nodal Oligorecurrent Prostate Cancer (PINPOINT)(PINPOINT) | not yet recruiting | N/A | 48 | Odense University HospitalOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT07642531 | A Modular Cloud Platform For Fertility Preservation | not yet recruiting | N/A | 140 | Biruni UniversityOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT07644754 | Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory Metastases(RIALTO) | not yet recruiting | N/A | 27 | University Hospital TuebingenOTHER | 0 | Jun 12, 2026 | clinicaltrials |
| NCT04745871 | Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ).(PREOP-PSMA) | terminated | N/A | 112 | University Hospital, BrestOTHER | 1 | Jun 11, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 29, 2026source: clinicaltrials